Refine Search
(2)
(17)
(66)
(96)

Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Onychomycosis (Tinea Unguium) - Pipeline Review, H2 2019’, provides an overview of the Onychomycosis (Tinea Unguium) pipeline landscape.

The report provides comprehensive information on the therapeutics under de...

Typhoid Fever - Pipeline Review, H2 2019

  • $2,000
  • August 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H2 2019’, provides an overview of the Typhoid Fever pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Typhoid Fever, com...

Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H1N1 Subtype Infections - Pipeline Review, H1 2019’, provides an overview of the Influenza A Virus, H1N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2019

  • $2,000
  • May 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H5N1 Subtype Infections - Pipeline Review, H1 2019’, provides an overview of the Influenza A Virus, H5N1 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Sepsis - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2019’, provides an overview of the Sepsis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis b...

Community Acquired Pneumonia - Pipeline Review, H1 2019

  • $2,000
  • April 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Community Acquired Pneumonia - Pipeline Review, H1 2019’, provides an overview of the Community Acquired Pneumonia pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Candidiasis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Candidiasis - Pipeline Review, H1 2019’, provides an overview of the Candidiasis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Candidiasis, complete ...

Coccidioidomycosis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Coccidioidomycosis - Pipeline Review, H1 2019’, provides an overview of the Coccidioidomycosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Coccidio...

Cryptococcosis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Cryptococcosis - Pipeline Review, H1 2019’, provides an overview of the Cryptococcosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Cryptococcosis, ...

Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Influenza A Virus, H3N2 Subtype Infections - Pipeline Review, H1 2019’, provides an overview of the Influenza A Virus, H3N2 Subtype Infections pipeline landscape.

The report provides comprehensive information on...

Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H1 2019’, provides an overview of the Severe Acute Respiratory Syndrome (SARS) pipeline landscape.

The report provides comprehensive information on the...

Anthrax - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Anthrax - Pipeline Review, H1 2019’, provides an overview of the Anthrax pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Anthrax, complete with analysi...

Genital Herpes - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Genital Herpes - Pipeline Review, H1 2019’, provides an overview of the Genital Herpes pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Genital Herpes, ...

Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bacillary Dysentery (Shigellosis) - Pipeline Review, H1 2019’, provides an overview of the Bacillary Dysentery (Shigellosis) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Osteomyelitis - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteomyelitis - Pipeline Review, H1 2019’, provides an overview of the Osteomyelitis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteomyelitis, com...